Liang, PA
Bailin Liang, Gilbertsville, PA US
Patent application number | Description | Published |
---|---|---|
20090137783 | CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses - Novel polypeptides (CNGH0010) and antibodies, including specified portions or variants, specific for at least one such CNGH0010 polypeptide, variant, or fragment thereof, as well as nucleic acids encoding such CNGH0010 polypeptides and antibodies, complementary nucleic acids, vectors, host cells, and methods of making and using thereof, are useful for therapeutic and diagnostic formulations, administration and devices. The aforesaid polypeptides can be used to generate human, primate, rodent, mammalian, chimeric, humanized and/or CDR-grafted anti-CNGH0010 antibodies. The CNGH0010 polypeptides and antibodies are used in modulating or treating at least one CNGH0010-related disease in a cell, tissue, organ, animal, or patient. Such diseases may include, but are not limited to, psoriasis, rheumatoid arthritis, emphysema, asthma, diabetes, autoimmune thyroiditis, inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, different types of dermatitis including allergic dermatitis, contact dermatitis, actinic keratosis, wound healing, scar formation, various renal diseases, various respiratory diseases, various diseases of reproductive organs, such as endometriosis, melanoma, squamous cell carcinoma, ovarian cancer, breast cancer, lung cancer, colon cancer, prostate cancer, renal cell carcinoma, Grave's diseases and other inflammatory and hyperproliferative diseases. | 05-28-2009 |
20090239258 | Anti-IL-6 Antibody Nucleic Acid Molecules and Methods - Anti-IL-6 antibody nucleic acids, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. | 09-24-2009 |
20110081355 | Methods of Diagnosing and Treating Conditions Using Anti-IL-6 Antibodies - Anti-IL-6 antibodies are used to treat IL-6 related conditions, such as rheumatoid arthritis, osteoarthritis, osteolysis, aseptic loosening of orthopedic implants, systemic lupus erythematosus, cutaneous lupus erythematosus, lupus nephritis, type 2 diabetes mellitus, chronic obstructive pulmonary disease, and renal cell carcinoma. | 04-07-2011 |
20120045453 | Anti-IL-6 Antibodies, Compositions, Methods and Uses - An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. | 02-23-2012 |
20130017208 | Anti-IL-6 Antibodies, Compositions, Methods and Uses - An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. | 01-17-2013 |
Jianming Liang, Chester Springs, PA US
Patent application number | Description | Published |
---|---|---|
20090034816 | Reduction of Lymph Tissue False Positives in Pulmonary Embolism Detection - A system for automatically detecting pulmonary emboli from medical image data includes receiving image data, automatically detecting one or more pulmonary embolism candidates from the image data, segmenting an airway tract from the image data, segmenting an artery structure from the image data, calculating a distance between each of the candidates and a nearest portion of the segmented airway, determining whether each of the candidates is within or outside of the segmented artery structure, rejecting candidates based on the calculated distance between each of the candidates and the nearest portion of the segmented airway and the determination as to whether each of the candidates is within or outside of the segmented artery structure, and indicating the location of the non-rejected candidates within the image data. | 02-05-2009 |
20090060307 | Tensor Voting System and Method - Described herein is a method and system for facilitating a tensor voting scheme. The tensor voting scheme includes determining at least one voter point and at least one receiver point from input data and determining a tensor vote directed from the receiver point to the voter point. | 03-05-2009 |
20090252394 | Computer Aided Detection of Pulmonary Embolism with Local Characteristic Features in CT Angiography - A method for computer aided detection of pulmonary emboli includes acquiring medical image data. A pulmonary embolism candidate comprising a cluster of voxels is identified. It is determined whether the candidate is a true pulmonary embolism or a false positive based on a spatial distribution of intensity values for the voxels of the cluster of voxels. The pulmonary embolism candidate is presented to a user when the candidate is determined to be a true pulmonary embolism. | 10-08-2009 |
Mary Liang, Pittsburgh, PA US
Patent application number | Description | Published |
---|---|---|
20160090387 | CALCIUM CHANNEL AGONISTS - Embodiments of calcium channel agonists, as well as methods of making and using the calcium channel agonists, are disclosed. The disclosed calcium channel agonists and corresponding salt forms have a structure according to general formula I: | 03-31-2016 |
Qianwa Liang, Drexel Hill, PA US
Patent application number | Description | Published |
---|---|---|
20150182643 | Novel Substrate Based PET Imaging Agents - The present application is directed to radiolabeled imaging agents comprising a radiolabel, and a substrate, pharmaceutical compositions comprising radiolabeled imaging agents, and methods of using the radiolabeled imaging agents. The present application is further directed to methods of preparing the radiolabeled imaging agent. Such imaging agents can used in imaging studies, such as Positron Emitting Tomography (PET) or Single Photon Emission Computed Tomography (SPECT). | 07-02-2015 |
Shaohong Liang, West Chester, PA US
Patent application number | Description | Published |
---|---|---|
20100311169 | Methods Of Generating High-Production Of Antibodies From Hybridomas Created By In Vitro Immunization - The invention provides methods for generating high titers of high-affinity antibodies from hybridoma cells produced by fusing myeloma cells with in vitro immunized donor cells. The hybridoma cells or mammalian expression cells with cloned antibody genes from the hybridomas producing the high-affinity antibodies may be mismatch repair defective due to defects of endogenous mismatch repair subunits of through expression of a dominant negative allele of a mismatch repair gene which allows the hybridoma cell to be hypermutable, may be rendered hypermutable by chemical means, or may be naturally mismatch repair deficient. High-affinity antibodies and high titer producer cells producing antibodies may be prepared by the methods of the invention. | 12-09-2010 |
Xiaoping Liang, Collegeville, PA US
Patent application number | Description | Published |
---|---|---|
20090098155 | Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease - The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of Aβ, lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to Aβ. In another aspect, the immunogenic fragment of Aβ is capable of elevating plasma Aβ levels. The immunogenic fragments comprise linear or multivalent peptides of Aβ. Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant. | 04-16-2009 |
20100143396 | Method for Preparing a Covalently Cross Linked Oligomer of Amyloid Beta Peptides - The invention relates to a method for the preparation of a stabilized cross-linked oligomer of amyloid beta using a near-zero length bifunctional cross-linking agent for use as an immunogen for the generation of antibodies for the treatment of Alzheimer's Disease and other conditions related to abnormal amyloid beta aggregation. A preferred bifunctional cross-linking agent is 1,5-difluoro-2,4-dinitrobenzene (DFDNB). | 06-10-2010 |
20100272714 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 10-28-2010 |
20110002949 | VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The invention provides a method for the treatment of a patient having a more severe form of Alzheimer's disease (AD), where the severe form of AD is characterized by pathogenic deposits of amyloid beta peptide (Aβ), comprising the administration of an immunogenic fragment of Aβ capable of inducing an immune response in the form of antibodies to specific to the pathogenic deposits of Aβ and, in particular, to neurotoxic forms of Aβ including N-terminally truncated forms of Aβ. The invention further provides a method for selecting a suitable immunogenic fragment of Aβ for the treatment of a more severe form of AD. | 01-06-2011 |
20110052611 | PEPTIDE CONJUGATE COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE - The invention provides compositions and methods for the treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient, such as Alzheimer's disease. Such methods entail administering an immunogenic fragment of Aβ, lacking a T-cell epitope, capable of inducing a beneficial immune response in the form of antibodies to Aβ. In another aspect, the immunogenic fragment of Aβ is capable of elevating plasma Aβ levels. The immunogenic fragments comprise linear or multivalent peptides of Aβ. Pharmaceutical compositions comprise the immunogenic fragment chemically linked to a carrier molecule which may be administered with an adjuvant. | 03-03-2011 |
20110159013 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLS, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 06-30-2011 |
20110212130 | LIVE, ATTENUATED RESPIRATORY SYNCYTIAL VIRUS - The present invention features live, attenuated respiratory syncytial viruses (RSV) useful as vaccines against RSV infection and/or the development of severe RSV-associated illnesses. The disclosed viruses are attenuated to the extent of being nonpathogenic when administered to a subject but substantially retain the antigenic and immunogenic properties of wild-type RSV. | 09-01-2011 |
20120171224 | Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLS, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42. | 07-05-2012 |
Xiaotao Liang, State College, PA US
Patent application number | Description | Published |
---|---|---|
20080224947 | Reconfigurable Frequency Selective Surfaces For Remote Sensing of Chemical and Biological Agents - An improved frequency selective surface (FSS) comprises a periodically replicated unit cell, the unit cell including a material having a first electrical conductivity in the presence of an external condition, and a second electrical conductivity in the absence of an external condition, or in the presence of a modified external condition. For example, the material may be a chemoresistive material, having an electrical conductivity that changes in the presence of a chemical or biological analyte, i.e. having a first value of electrical conductivity in the presence of the analyte, and a second value of electrical conductivity in the absence of the analyte. | 09-18-2008 |
Yin Liang, Ambler, PA US
Patent application number | Description | Published |
---|---|---|
20110009347 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES - The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein. | 01-13-2011 |
20160089360 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES - The present invention is directed to co-therapy and methods for the treatment and prevention of glucose-related disorders such as Type 2 diabetes mellitus and Syndrome X. The present invention is further directed to pharmaceutical compositions for the co-therapy and methods described herein. | 03-31-2016 |
Yu-Ming Liang, Bethlehem, PA US
Patent application number | Description | Published |
---|---|---|
20140021663 | LANCE FOR WIRE FEEDING - A lance for feeding an additive wire into a quantity of molten metal below the surface of the molten metal. The lance has an inlet end which receives additive wire and an outlet end which dispenses the additive wire. The lance has an exterior sleeve of cardboard which has an inner surface. A portion of the inner surface of the exterior sleeve contacts an interior sleeve made of a refractory material. At the inlet end of the lance is a cardboard inlet outer sleeve and a cardboard inlet inner sleeve inside of the outer sleeve. The lance can have a coupling for fitting to a wire feeding apparatus. | 01-23-2014 |